The following recently-published papers address important issues in health care value assessment.
In an article in BMC Health Services Research, by Allison Oaks and colleagues they discuss systemic overuse in the commercially insured population. Findings suggest that systematic overuse is found at a regional level and stays persistent over time. Read full article here.
In a study from The National Institute for Health Care Management Foundation, researchers found a large percentage of x-rays and MRIs provided within 30 days of an initial office visit were deemed inappropriate, costing commercial insurers between $4.6 and $5.5 million over the two-year study period. Read full article here.
In an editorial piece by Mark Fendrick and Darrell George in AJMC, they discuss the “Drug Price Iceberg”, cautioning that when it comes to the political iceberg of drug prices, there is more than meets the eye. Read full article here.
In a study recently published in JAMA Internal Medicine, Badgery-Parker and colleagues study the level of hospital acquired complications associated with low-value care in Australia. Findings suggest that the use of 7 low value care procedures in harming some patients, consuming additional hospital resources and potentially delaying care for other patients. Read full article here.
In a follow on to the low-value care webinar hosted by the University of Michigan’s Center for Value-Based Insurance Design and VBID Health, Laura Joszt from AJMC discusses the elements in the webinar including the difficulties in reducing the use of low-value care. Read full article here.
In a study published by Betsy Cliff, Richard Hirth and Mark Fendrick in Health Affairs, they discuss the likelihood of high and low value service use in the first two years after an insurance benefit change. Their findings suggest that interventions aimed at increasing high-value preventive services can cause spillovers to low value services and should include deterrents to low value care. Read full article here.
In a JAMA research letter, Dr. Kevin Platt and colleagues discuss their study on the overuse of self-monitored glucose testing in Type 2 diabetic patients, and the cost it has on the health care system. Read the full article here.
In a study by Aaron Schwartz and colleagues, they conclude physician practices may substantially contribute to low-value service usage but it is difficult to which physicians are more wasteful without measuring their behavior. Read the full article here.
In a meta-analysis conducted by Dr. Daniel Morgan and colleagues to understand medical overuse, they found many current practices represent overuse while other services were used inappropriately. Read the full article here.
The Research Consortium for Health Care Value Assessment is a partnership between Altarum and VBID Health, with funding from the PhRMA Foundation as part of its Value Assessment Initiative, established to promote the pursuit of value in health care delivery in the U.S. Follow us at @ValueConsortium.